Resibufogenin suppresses transforming growth factor ‐β‐activated kinase 1‐mediated nuclear factor‐κB activity through protein kinase C‐dependent inhibition of glycogen synthase kinase 3

Cancer Science, EarlyView.

Source: Cancer Science - September 24, 2018 Category: Cancer & Oncology Authors: Lu Liu, Yang Liu, Xiaojia Liu, Na Zhang, Genxiang Mao, Qingxuan Zeng, Mingxiao Yin, Danqing Song, Hongbin Deng Source Type: research